5.60 USD
▼-0.76-11.95%
盘后 8.68 0.00%
2026-09-16
市值
$2.89M
市盈率
—
EPS
-59.70
股息率
—
52 周区间
4.56 – 138.65
成交量
180.31K
Beta
-1.11
目标价
—
52W 低 4.5652W 高 138.65
价格走势
公司简介
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cance...